Revenue
attach_money0M USD
-
SABSSAB Biotherapeutics, Inc.$ --
SAB Biotherapeutics, Inc.
SABS
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q4Updated: 12/31/2025
Operating Income
trending_up-16M USD
-
Net Income
verified-17M USD
-
EPS
paid-2.39$
-
Revenue
$0
MISS
$125,000
$125,000
$100,000
$100,000
$450,000
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Net Income
$-16.9M
BEAT
$-65.8M
$-5.2M
$-48.8M
$-10.1M
$-28.1M
$45.4M
$-13.5M
$-16.9M
$-156.2M
$13.3M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Surprise History
ActualEstimate
FY2025MISS